Literature DB >> 33752693

The immune response and aging in chronic inflammatory demyelinating polyradiculoneuropathy.

Kathleen M Hagen1, Shalina S Ousman2.   

Abstract

Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) consists of various autoimmune subtypes in which the peripheral nervous system (PNS) is attacked. CIDP can follow a relapsing-remitting or progressive course where the resultant demyelination caused by immune cells (e.g., T cells, macrophages) and antibodies can lead to disability in patients. Importantly, the age of CIDP patients has a role in their symptomology and specific variants have been associated with differing ages of onset. Furthermore, older patients have a decreased frequency of functional recovery after CIDP insult. This may be related to perturbations in immune cell populations that could exacerbate the disease with increasing age. In the present review, the immune profile of typical CIDP will be discussed followed by inferences into the potential role of relevant aging immune cell populations. Atypical variants will also be briefly reviewed followed by an examination of the available studies on the immunology underlying them.

Entities:  

Keywords:  Aging; Chronic inflammatory demyelinating polyradiculoneuropathy; Immune system; Immunosenescence; Peripheral nervous system

Year:  2021        PMID: 33752693      PMCID: PMC7983397          DOI: 10.1186/s12974-021-02113-2

Source DB:  PubMed          Journal:  J Neuroinflammation        ISSN: 1742-2094            Impact factor:   8.322


  130 in total

1.  Recurrent polyneuropathies and their corticosteroid treatment; with five-year observations of a placebo-controlled case treated with corticotrophin, cortisone, and prednisone.

Authors:  J H AUSTIN
Journal:  Brain       Date:  1958-06       Impact factor: 13.501

2.  Ultrasound aspects in therapy-naive CIDP compared to long-term treated CIDP.

Authors:  Alexander Grimm; Debora Vittore; Victoria Schubert; Maria Rasenack; Bernhard F Décard; Bianka Heiling; Nadin Hammer; Hubertus Axer
Journal:  J Neurol       Date:  2016-03-26       Impact factor: 4.849

3.  Spinal root and plexus hypertrophy in chronic inflammatory demyelinating polyneuropathy.

Authors:  A J Duggins; J G McLeod; J D Pollard; L Davies; F Yang; E O Thompson; J R Soper
Journal:  Brain       Date:  1999-07       Impact factor: 13.501

Review 4.  Progress in diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  Carina Bunschoten; Bart C Jacobs; Peter Y K Van den Bergh; David R Cornblath; Pieter A van Doorn
Journal:  Lancet Neurol       Date:  2019-05-07       Impact factor: 44.182

5.  Macrophage clustering as a diagnostic marker in sural nerve biopsies of patients with CIDP.

Authors:  C Sommer; S Koch; M Lammens; A Gabreels-Festen; G Stoll; K V Toyka
Journal:  Neurology       Date:  2005-12-27       Impact factor: 9.910

6.  Clinicopathologic findings and prognosis of chronic inflammatory demyelinating polyneuropathy.

Authors:  C Bouchard; C Lacroix; V Planté; D Adams; F Chedru; J M Guglielmi; G Said
Journal:  Neurology       Date:  1999-02       Impact factor: 9.910

7.  Hypertrophic neuritis due to chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): a postmortem pathological study.

Authors:  M Matsuda; S Ikeda; S Sakurai; A Nezu; N Yanagisawa; T Inuzuka
Journal:  Muscle Nerve       Date:  1996-02       Impact factor: 3.217

8.  Atypical CIDP: diagnostic criteria, progression and treatment response. Data from the Italian CIDP Database.

Authors:  Pietro Emiliano Doneddu; Dario Cocito; Fiore Manganelli; Raffaella Fazio; Chiara Briani; Massimiliano Filosto; Luana Benedetti; Anna Mazzeo; Girolama Alessandra Marfia; Andrea Cortese; Brigida Fierro; Stefano Jann; Ettore Beghi; Angelo Maurizio Clerici; Marinella Carpo; Angelo Schenone; Marco Luigetti; Giuseppe Lauria; Giovanni Antonini; Tiziana Rosso; Gabriele Siciliano; Guido Cavaletti; Giuseppe Liberatore; Lucio Santoro; Erdita Peci; Stefano Tronci; Marta Ruiz; Stefano Cotti Piccinelli; Antonio Toscano; Giorgia Mataluni; Laura Piccolo; Giuseppe Cosentino; Mario Sabatelli; Eduardo Nobile-Orazio
Journal:  J Neurol Neurosurg Psychiatry       Date:  2018-10-08       Impact factor: 10.154

9.  Incidence and Prevalence of Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A Systematic Review and Meta-Analysis.

Authors:  Merel C Broers; Carina Bunschoten; Daan Nieboer; Hester F Lingsma; Bart C Jacobs
Journal:  Neuroepidemiology       Date:  2019-01-22       Impact factor: 3.282

10.  Nodes of ranvier and paranodes in chronic acquired neuropathies.

Authors:  Carmen Cifuentes-Diaz; Odile Dubourg; Theano Irinopoulou; Marc Vigny; Sylvie Lachkar; Laurence Decker; Patrick Charnay; Natalia Denisenko; Thierry Maisonobe; Jean-Marc Léger; Karine Viala; Jean-Jacques Hauw; Jean-Antoine Girault
Journal:  PLoS One       Date:  2011-01-18       Impact factor: 3.240

View more
  1 in total

Review 1.  Pathophysiology of the Different Clinical Phenotypes of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP).

Authors:  Edyta Dziadkowiak; Marta Waliszewska-Prosół; Marta Nowakowska-Kotas; Sławomir Budrewicz; Zofia Koszewicz; Magdalena Koszewicz
Journal:  Int J Mol Sci       Date:  2021-12-24       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.